Gastric atrophy is correlated to the activity of Helicobacter pylori-induced chronic gastritis

2001 ◽  
Vol 120 (5) ◽  
pp. A656-A656
Author(s):  
M CAVICCHI ◽  
J AUROUX ◽  
J NHIEU ◽  
J DELCHIER ◽  
D LAMARQUE
2001 ◽  
Vol 120 (5) ◽  
pp. A656
Author(s):  
Maryan Cavicchi ◽  
Jean Auroux ◽  
Jeanne Tran van Nhieu ◽  
Jean Charles Delchier ◽  
Dominique Lamarque

2019 ◽  
Author(s):  
M Kadi ◽  
M Eljihad ◽  
M Tahiri Joutei-Hassani ◽  
W Badre ◽  
W Hliwa ◽  
...  

2019 ◽  
pp. 28-32
Author(s):  
Van Huy Tran

Background and aims: Efficacy with substitution of tetracycline with amoxicillin, an antibiotics having a very low resistance rate and a high tolerability, in bismuth quadruple therapy (BQT) have not been studied in Vietnam. Our study aimed to evaluate the efficacy and tolerability of modified BQT vs. standard BQT for first-line Helicobacter pylori eradication. Patients and methods: This is a randomized, prospective study. 120 patients with H.pylori positive-chronic gastritis were randomly divided into two groups. The RBMA group containing rabeprazole 20 mg, bismuth subsalicylic 524mg, metronidazole 500mg, amoxicillin 1000mg, all 2 times a day, for 14 days. The RBMT group received rabeprazole, bismuth subsalicylic, metronidazole and tetracycline. Evaluation for compliance and drug-related side effects were evaluated at the end of two weeks. 4-6 weeks after the end of treatment, the H.pylori eradication rate was determined by the C13urease breath test. Results: Eradication rate was not statistically significative different between the RBMA and the RBMT: 91.2%; 95% confidence interval, 78.2% - 96.7%) vs. 90%; 95% CI, 81.6% - 96.3%) by per-protocol analysis (p = 0.42) and 86.7% (95%CI, 75.84% - 93.09%) vs. 75% (95%CI, 62.1% - 85.3%) by intention-to-treat analysis (ITT, p = 0.06). Adverse effects were significant higher in the RBMT group than in the RBMA group (48.3% vs. 26.7%; p = 0.071) and rate of good compliance was significantly higher in RBMA group than in RBMT group (p < 0.05). Conclusion: The modified BQT including rabeprazole, bismuth, metronidazole and amoxicillin achieved a fairly high rate of H.pylori infection eradication with a higher compliance and lower rate of adverse effects compared to the BQT in patients with chronic gastritis. Further studies need to conduct to confirm this new regimens as a first-line therapy in our country. Key words: Modified bismuth quadruple therapy, BQT, Helicobacter pylori eradication


Gene Reports ◽  
2021 ◽  
Vol 23 ◽  
pp. 101165
Author(s):  
Raed Obaid Saleh ◽  
Najwa Shihab Ahmed ◽  
Emad A. Ewais ◽  
Aqeel Shakir Mahmood ◽  
Ahmed R. Sofy

Gut ◽  
1990 ◽  
Vol 31 (11) ◽  
pp. 1230-1236 ◽  
Author(s):  
L L Thomsen ◽  
J B Gavin ◽  
C Tasman-Jones

Sign in / Sign up

Export Citation Format

Share Document